OpenAI Eyes $30 Billion Raise at $1.4 Trillion Valuation

OpenAI is currently in discussions with investors to secure at least $30 billion in a pre-IPO bridge funding round, according to a report from Bloomberg. This massive influx of capital would value the artificial intelligence pioneer at approximately $1.4 trillion. The potential fundraising highlights intense investor appetite to back the creator of ChatGPT before its eventual transition to public markets, which has now been pushed back.

The talks follow a highly successful period of financial growth for the company. Although rival Anthropic briefly outpaced OpenAI earlier this year, OpenAI successfully rebounded by refocusing its strategy on core domains such as software coding. This pivot triggered a 70 percent surge in run-rate revenue since July, culminating in an annualized run-rate of $40 billion in August. This rapid commercial acceleration has re-established OpenAI as the dominant force in the generative AI landscape.

This proposed bridge round represents a significant step up from OpenAI's previous financial milestone in March, when it raised $122 billion at an $852 billion valuation. While that earlier transaction was initially expected to be the company's final private funding event before going public, plans have shifted. Chief Executive Officer Sam Altman recently ruled out a public debut in 2026. Altman explained this delay by emphasizing the need to prioritize safety, stating it is unacceptable to risk "killing everybody by the end of the decade."

For AI practitioners and enterprise developers, this massive capital injection and delayed IPO signal long-term stability and sustained platform support. With tens of billions of dollars in fresh funding, OpenAI can continue to subsidize heavy compute costs, refine its developer APIs, and advance its frontier models without the immediate pressure of quarterly public earnings reports. Practitioners can confidently build on OpenAI's infrastructure, knowing the company has the financial runway to prioritize safety research alongside aggressive product development.